Why the study?
Does the addition of tolazoline to renal arteriography increase toxic effects in patients undergoing renal arteriograms?
Does the addition of tolazoline to renal arteriography increase toxic effects in patients undergoing renal arteriograms?
The use of tolazoline as a vasodilator during renal arteriography appears safe, with no significant hemodynamic or organ toxicity, though it may cause shaking chills in a small minority of patients.
Answers are grounded in this paper and cite their sources.
Supports tolazoline safety in renal arteriography without major toxicities; leaves open randomized confirmation before routine adoption.
AJR 137:381-386, August 1981 0361-803X/81 /1372-0381 $00.00 © American Roentgen Ray Society One-hundred renal arteriograms obtained with the vasodilator tolazoline were compared with 100 control studies to investigate toxic effects. The addition of tolazoline to renal arteriography was not associated with hemodynamic fluctuations, cardiac toxicity, gastrointestinal complaints, headache, dizziness, abdominal pain, or renal toxicity. A shaking chills reaction was identified in 4% of the tolazoline-treated group. Several variables, such as prior contrast medium injection, were associated with minimal hemodynamic changes.
No takes yet. Share an insight, caveat, or question.
Dahlin et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: